FIRST SOLAR, INC.·4

Mar 10, 8:56 PM ET

Gloeckler Markus 4

4 · FIRST SOLAR, INC. · Filed Mar 10, 2026

Research Summary

AI-generated summary of this filing

Updated

First Solar (FSLR) CTO Markus Gloeckler Sells Shares

What Happened
Markus Gloeckler, Chief Technology Officer of First Solar (FSLR), had multiple restricted stock units (RSUs) vest on March 6, 2026 and received a new RSU award the same day. The vesting/conversion resulted in 3,150 shares issued (conversion/exercise entries at $0). On March 9, 2026 he disposed of 1,325 shares in sales at $190.36 per share, generating total reported proceeds of $252,227. The filing also shows a grant of 3,066 RSUs on March 6, 2026 (no immediate cash value).

Key Details

  • Transaction dates: March 6, 2026 (RSU vesting/conversion and new grant); March 9, 2026 (sales). Filing date: March 10, 2026 (timely).
  • Sales: 320, 199, 358 and 448 shares sold on Mar 9, 2026 at $190.36 each — total 1,325 shares for $252,227.
  • Acquisitions/conversions: 760 + 471 + 852 + 1,067 = 3,150 shares issued on Mar 6, 2026 (reported as exercise/conversion of derivatives at $0).
  • Grant: 3,066 RSUs granted on Mar 6, 2026 (no cash paid).
  • Footnotes: vesting represents issuance of common stock from prior RSU grants (F1–F4, F6). Some shares may have been sold by the issuer to satisfy tax-withholding obligations on vesting (F5). New RSUs vest annually (typically 20–25% per year depending on grant; see F7–F11).
  • Shares owned after the transactions: not specified in the provided filing details.

Context
The March 6 entries reflect RSU vesting/conversion (derivative settlement) rather than a cash purchase; the March 9 sales appear to be routine disposals (including tax withholding sales noted in footnotes). Routine sales to cover taxes or liquidity needs are common and do not necessarily signal a change in insider outlook. The filing was made within the expected SEC Form 4 timeframe.

Insider Transaction Report

Form 4
Period: 2026-03-06
Gloeckler Markus
Chief Technology Officer
Transactions
  • Sale

    Common Stock

    [F5]
    2026-03-09$190.36/sh320$60,91510,867 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-06+7608,797 total
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-03-06+4719,268 total
  • Exercise/Conversion

    Common Stock

    [F3]
    2026-03-06+85210,120 total
  • Exercise/Conversion

    Common Stock

    [F4]
    2026-03-06+1,06711,187 total
  • Sale

    Common Stock

    [F5]
    2026-03-09$190.36/sh199$37,88210,668 total
  • Sale

    Common Stock

    [F5]
    2026-03-09$190.36/sh358$68,14910,310 total
  • Sale

    Common Stock

    [F5]
    2026-03-09$190.36/sh448$85,2819,862 total
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F7]
    2026-03-067600 total
    Common Stock (760 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F8]
    2026-03-06471942 total
    Common Stock (471 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F9]
    2026-03-068521,705 total
    Common Stock (852 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F10]
    2026-03-061,0673,204 total
    Common Stock (1,067 underlying)
  • Award

    Restricted Stock Units

    [F6][F11]
    2026-03-06+3,0663,066 total
    Common Stock (3,066 underlying)
Footnotes (11)
  • [F1]Represents shares of common stock issued upon vesting of 20% of the restricted stock units granted on March 6, 2021.
  • [F10]The restricted stock units were granted on March 6, 2025 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on March 6, 2025 vest annually at a rate of 25% on each anniversary of the grant date, commencing on the first anniversary of the grant date.
  • [F11]The restricted stock units were granted on March 6, 2026 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on March 6, 2026 vest annually at a rate of 25% on each anniversary of the grant date, commencing on the first anniversary of the grant date.
  • [F2]Represents shares of common stock issued upon vesting of 20% of the restricted stock units granted on March 6, 2023.
  • [F3]Represents shares of common stock issued upon vesting of 25% of the restricted stock units granted on March 6, 2024.
  • [F4]Represents shares of common stock issued upon vesting of 25% of the restricted stock units granted on March 6, 2025.
  • [F5]Represents shares of common stock sold by the Issuer to satisfy certain tax withholding obligations with the vesting of the restricted stock units.
  • [F6]Each restricted stock unit represents the right to receive, upon vesting, one share of the Issuer's common stock in accordance with the Issuer's 2020 Omnibus Incentive Compensation Plan.
  • [F7]The restricted stock units were granted on March 6, 2021 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on March 6, 2021 vest annually at a rate of 20% on each anniversary of the grant date, commencing on the first anniversary of the grant date.
  • [F8]The restricted stock units were granted on March 6, 2023 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on March 6, 2023 vest annually at a rate of 20% on each anniversary of the grant date, commencing on the first anniversary of the grant date.
  • [F9]The restricted stock units were granted on March 6, 2024 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on March 6, 2024 vest annually at a rate of 25% on each anniversary of the grant date, commencing on the first anniversary of the grant date.
Signature
/s/ Jason E. Dymbort, attorney-in-fact|2026-03-10

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT